TMCnet News

Research and Markets: Global Hemophilia Market Report: 2015 Edition: Market is Intense Among Large Players like with Baxter International, Novo Nordisk and Pfizer
[May 25, 2015]

Research and Markets: Global Hemophilia Market Report: 2015 Edition: Market is Intense Among Large Players like with Baxter International, Novo Nordisk and Pfizer


Research and Markets (http://www.researchandmarkets.com/research/j63nc2/global_hemophilia) has announced the addition of the "Global Hemophilia Market Report: 2015 Edition" report to their offering.

Hemophilia is an inherited or acquired bleeding disorder that prevents blood from clotting. People with hemophilia lack, either partially or completely, an essential clotting factor needed to form stable blood clots. People with hemophilia do not bleed any faster than normal, but they can bleed for a longer time. Hemophilia is quite rare and about 1 in 10,000 people are born with it, around 0.42 million people live with hemophilia. Hemophilia patients need to replace the missing factor through infusions. The main treatment is called replacement therapy, in which concentrates of clotting factor VIII (for hemophilia A) or clotting factor IX (for hemophilia B) are injected into a vein. Mre people suffer with hemophilia A in comparison to hemophilia B and Inhibitors. The US accounts for the major population suffering with hemophilia globally.



The key trends observed in the market include introduction of new products increased competition in rFVIII market and adoption of prophylactic treatment. On the development front, there has been an increase in the launch of new products like next-Generation long-acting Factor VIII and ready-to-use product by Novo Nordisk. But there are certain challenges too which include high risk and cost associated with new drugs, rising cost of hemophilia treatment and low switching rate among patients. The future drivers of the industry are increased rate of diagnosis and treatment, rising male population and global healthcare expense among others.

The report provides a comprehensive study of hemophilia market globally and also provides detailed information for key regional markets. The competition in the global hemophilia market is intense among large players like Baxter International Inc., Novo Nordisk and Pfizer. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.


Key Topics Covered:

1. Overview

2. Market Analysis

3. Market Dynamics

4. Competitive Landscape

5. Company Profiles

6. Market Outlook

Companies Mentioned

- Baxter International Inc.

- Novo Nordisk

- Pfizer

For more information visit http://www.researchandmarkets.com/research/j63nc2/global_hemophilia


[ Back To TMCnet.com's Homepage ]